Transanal excision of XXXX .

@entity1 @entity48532 @entity548 @entity55 @entity5 @entity957 @entity189 @entity158 @entity583 @entity420
Twenty-two @entity1 and 16 @entity1 with a mean age of 67 years were treated for @entity189 by transanal excision. @entity1 presented with @entity548 (63%), change in bowel habits (11%), @entity158 (4%), or were asymptomatic and discovered on screening proctosigmoidoscopy (22%). The @entity5 were located from the anal verge to 8 cm proximally and ranged in size from 1 to 4 cm. Pathologic findings included @entity420 (92%), @entity957 (4%), and @entity48532 (4%). Postoperative hospitalization averaged two days (0 to 29 days). One @entity1 died of a perioperative @entity583 for an operative mortality of 3 per cent. Morbidity was 7 per cent and included urinary retention and @entity55 . Postoperative radiation therapy was administered to 11 @entity1 with either undifferentiated @entity5 or invasion into the muscularis propria. Follow-up in these 38 @entity1 averaged 30 months. One @entity1 died of @entity189 , and two @entity1 developed local recurrence that was treated successfully by a low anterior resection or abdominoperineal resection. Transanal excision of @entity189 can be performed in properly selected @entity1 with good overall survival and local control.
